- Home
- NIU vs ENGN Comparison
NIU vs ENGN Comparison
Compare NIU & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIU
- ENGN
- Stock Information
- Founded
- NIU 2014
- ENGN 1999
- Country
- NIU China
- ENGN Canada
- Employees
- NIU N/A
- ENGN N/A
- Industry
- NIU Auto Manufacturing
- ENGN
- Sector
- NIU Consumer Discretionary
- ENGN
- Exchange
- NIU Nasdaq
- ENGN Nasdaq
- Market Cap
- NIU 216.7M
- ENGN 204.3M
- IPO Year
- NIU 2018
- ENGN N/A
- Fundamental
- Price
- NIU $3.37
- ENGN $3.75
- Analyst Decision
- NIU
- ENGN Buy
- Analyst Count
- NIU 0
- ENGN 7
- Target Price
- NIU N/A
- ENGN $23.29
- AVG Volume (30 Days)
- NIU 1.1M
- ENGN 97.3K
- Earning Date
- NIU 08-11-2025
- ENGN 06-12-2025
- Dividend Yield
- NIU N/A
- ENGN N/A
- EPS Growth
- NIU N/A
- ENGN N/A
- EPS
- NIU N/A
- ENGN N/A
- Revenue
- NIU $477,578,753.00
- ENGN N/A
- Revenue This Year
- NIU $41.32
- ENGN N/A
- Revenue Next Year
- NIU $24.38
- ENGN N/A
- P/E Ratio
- NIU N/A
- ENGN N/A
- Revenue Growth
- NIU 26.51
- ENGN N/A
- 52 Week Low
- NIU $1.66
- ENGN $2.65
- 52 Week High
- NIU $4.90
- ENGN $11.00
- Technical
- Relative Strength Index (RSI)
- NIU 46.08
- ENGN 56.32
- Support Level
- NIU $3.31
- ENGN $2.95
- Resistance Level
- NIU $3.44
- ENGN $3.44
- Average True Range (ATR)
- NIU 0.22
- ENGN 0.26
- MACD
- NIU -0.02
- ENGN 0.08
- Stochastic Oscillator
- NIU 30.86
- ENGN 77.62
About NIU Niu Technologies
Niu Technologies designs, manufactures and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycle, mopeds and bicycle series, including the NQi, MQi, UQi, F series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.